A Refunding Scheme to Incentivize Narrow-Spectrum Antibiotic Development

The rapid rise of antibiotic resistance is a serious threat to global public health. The situation is exacerbated by the “antibiotics dilemma”: Developing narrow-spectrum antibiotics against resistant bacteria is most beneficial for society, but least attractive for companies, since their usage and...

Descripción completa

Detalles Bibliográficos
Autores principales: Böttcher, Lucas, Gersbach, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023703/
https://www.ncbi.nlm.nih.gov/pubmed/35451653
http://dx.doi.org/10.1007/s11538-022-01013-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023703/
https://www.ncbi.nlm.nih.gov/pubmed/35451653
http://dx.doi.org/10.1007/s11538-022-01013-7

Ejemplares similares